New Jersey Urology, LLC
Voorhees, New Jersey, United States
Urology clinic in Voorhees Township, New Jersey
136 NJ-73 Suite A &B, Voorhees Township, NJ 08043
About New Jersey Urology, LLC
"As an all-inclusive practice, NJU is dedicated to providing comprehensive individualized treatment for all patients."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Exosome Diagnostics, Inc.
3
Bayer
2
Bioniche Life Sciences Inc.
2
Spectrum Pharmaceuticals, Inc
2
Spinal Singularity
2
AEterna Zentaris
1
Allena Pharmaceuticals
1
BHR Pharma, LLC
1
Calyxo, Inc.
1
Coloplast A/S
1
Clinical Trials at New Jersey Urology, LLC
During the past decade, New Jersey Urology, LLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on
average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
2006-11-01
2011-07-01
Completed
129
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
2007-04-01
2012-01-01
Completed
802
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
2008-03-01
2009-08-01
Completed
528
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
2010-11-01
2013-12-01
Terminated
84
The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study
2010-12-01
2014-01-01
Completed
113
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
2011-05-01
2012-01-01
Terminated
15
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
2011-03-01
2013-07-01
Completed
136
Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
2011-07-01
2014-03-01
Terminated
66
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "New Jersey Urology, LLC" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Exosome Diagnostics, Inc." with 3 trials
sponsored, "Bayer" with 2 trials sponsored, "Bioniche Life Sciences Inc." with 2 trials sponsored and "Spectrum Pharmaceuticals, Inc"
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Urology, LLC"
#1 collaborator was "Allergan" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Endo Pharmaceuticals" with 1 trials as a collaborator and "FKD Therapies Oy" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at New Jersey Urology, LLC
According to Clinical.Site data, the most researched conditions in "New Jersey Urology, LLC" are
"Bladder Cancer" (3 trials), "Prostate Cancer" (3 trials), "Urinary Bladder Neoplasms" (3 trials), "Neurogenic Bladder" (2 trials) and "Overactive Bladder" (2 trials). Many other conditions were trialed in "New Jersey Urology, LLC" in a lesser frequency.
Clinical Trials Intervention Types at New Jersey Urology, LLC
Most popular intervention types in "New Jersey Urology, LLC" are "Drug" (22 trials), "Biological" (5 trials), "Device" (5 trials), "Diagnostic Test" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Cetrelimab" (3 trials), "TAR-200" (3 trials), "Apalutamide" (2 trials) and "Apaziquone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at New Jersey Urology, LLC
The vast majority of trials in "New Jersey Urology, LLC" are
17 trials for "Male" genders, 16 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at New Jersey Urology, LLC
Currently, there are NaN active trials in "New Jersey Urology, LLC".
undefined are not yet recruiting,
7 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in New Jersey Urology, LLC,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in New Jersey Urology, LLC, 4 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".